A new decoration for nitric oxide synthase – a Zn(Cys)4 site  by Ludwig, Martha L & Marletta, Michael A
Minireview R73
A new decoration for nitric oxide synthase – a Zn(Cys)4 site
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Intense interest in the action and synthesis of nitric oxide
has fuelled structural studies of nitric oxide synthase
(NOS). The monomeric and dimeric heme domains of
inducible NOS were the first NOS structures to be
described. A recent independent analysis of the
corresponding heme domains from endothelial NOS
confirms most of the features found earlier and also
reveals a novel Zn(Cys)4 center — a new feature for NOS. 
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Catalysis by NOS
Nitric oxide (•NO) is a key molecule [1,2] that plays vital
roles in signal transduction, vasodilation and the inflam-
matory response. The control of •NO levels and the reg-
ulation of •NO synthesis are therefore of fundamental
importance and, as a consequence, much effort has been
directed at the study of nitric oxide synthase (NOS). 
The reaction catalyzed by NOS is shown in Figure 1. The
substrate L-arginine undergoes an overall five-electron
oxidation in the conversion to citrulline and •NO with
NG-hydroxy-L-arginine (L-NHA) as an intermediate.
Three isoforms of NOS are known to exist in mammals:
inducible (iNOS), endothelial (eNOS) and neuronal
(nNOS). Each isomer functions as a dimer and has a
similar overall fold comprising two major domains, an 
N-terminal oxygenase domain and a C-terminal reductase
domain, joined by a short calmodulin (CaM) binding
region. The oxidation of L-arginine is catalyzed by the 
N-terminal heme-containing oxygenase domain of NOS;
dimerization of the domains is essential for this activity.
Reducing equivalents required to generate ferrous heme
(Figure 2) are provided by NADPH via the C-terminal
reductase domains that incorporate FAD and FMN and
are related to the cytochrome P450 reductase family of
proteins. The formation of •NO from L-arginine not only
requires heme and the cofactors of the reductase domains,
but also 6(R)-tetrahydro-L-biopterin (H4B) [3–5].
Electron transfer in native NOS has been studied in some
detail. Reducing equivalents derived from NADPH are
shuttled through the flavoprotein reductase to the heme.
Efficient electron transfer from the reductase moiety to the
heme of NOS depends on coupling by Ca2+–CaM, which
binds to a short region following the oxygenase domain.
The constitutive NOS isoforms (eNOS and nNOS) are
strictly regulated by the Ca2+–CaM interaction, in keeping
with the role of these isoforms in transient •NO synthesis
in signal transduction. On the other hand, the inducible
isoform iNOS copurifies with Ca2+ and CaM. This very
tight Ca2+–CaM interaction probably involves multiple
recognition sites on NOS, and leads to an enzyme that is
‘constitutively’ active. This activity is consistent with the
function of iNOS in the host response to infection, which
requires prolonged •NO formation in the vicinity of the
invading organism.
The roles of heme and H4B in the oxidation of arginine
are incompletely understood. Mounting evidence suggests
a direct role for the heme, together with its proximal cys-
teine ligand, in the conversion of L-NHA to citrulline and
•NO. Support for the participation of heme has principally
come from studies of the ‘peroxide shunt’, which utilizes
peroxide in place of NADPH and O2 [6,7]. The data are
consistent with the formation of a heme–Fe(III)–peroxide
nucleophile as an intermediate (Figure 2). In the normal
oxidation of L-NHA, the second electron required to form
the ferric–peroxide species has been proposed to come
from L-NHA, thereby setting the stage for the one-elec-
tron chemistry that is required to produce •NO (Figure 2).
The conversion of L-arginine to L-NHA has been more
difficult to characterize. The strongest piece of evidence
implicating the heme in L-NHA formation is the inhibi-
tion of the reaction by CO. However, attempts to generate
reactive heme–oxy species fail to short-circuit the reaction
pathway. Specifically, neither peroxide nor a source of
oxene oxygen, such as iodosobenzene, will support L-NHA
formation from L-arginine [7]. Although its exact role in
catalysis is not clear, the reduced H4B is essential to the
formation of L-NHA from L-arginine. Rusche et al. showed
that H4B-free NOS was unable to hydroxylate L-arginine
in the presence of NADPH [4]. Moreover, the H4B-free
heme domain is incapable of oxidizing L-arginine with
reducing equivalents supplied by dithionite, whereas the
H4B-bound form is able to carry out this reaction (AR
Hurshman and MAM, unpublished results).
The reduction of heme by NADPH occurs slowly in H4B-
free NOS [4]. This and other observations might implicate
H4B in electron transfer, but the known interdependence
of H4B binding and dimer stability [8] might also point to
a structural rather than functional role for H4B. The diffi-
culty in reaching a consensus about the details of the reac-
tion mechanism and about the roles of the NOS cofactors
is largely due to a lack of understanding of the require-
ment for H4B in the reaction. Any light that the structures
might shed on this aspect of NOS enzymology would
indeed be welcome.
The oxygenase dimers: comparisons of the structures
derived from iNOS and eNOS
The first NOS structure analysis, by Tainer and coworkers
[9], visualized the fold of residues 115–458 (or ∆114), a
monomeric fragment from the heme-containing oxygenase
domain of iNOS from murine macrophages. Although this
fragment is enzymatically inactive [8], the initial structure
nevertheless revealed the principal features of the NOS
oxygenase fold and the determinants of heme binding. This
structure was followed quickly [10] by the determination
in the same laboratory of structures of a dimeric oxygen-
ase species, comprising residues 67–498, that included the
essential H4B cofactor. The dimer structures were com-
plexes with either the substrate arginine or the product
analog thiocitrulline, and identified a binding site at the
distal side of the heme where L-arginine may react with
heme–oxy species, such as those proposed in Figure 2. The
structures also revealed the interactions that bind H4B and
defined the mutual orientation of H4B and heme cofactors.
The oxygenase folds into a single flattened domain with a
‘winged’ central β sheet [9,10] that arches over the distal
side of the heme (Figure 3). As already well established by
UV–visible and Raman spectroscopy and by the analysis of
mutants, cysteine is the proximal ligand to Fe in iNOS and
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Figure 1
The reaction catalyzed by nitric oxide
synthase. In the first step L-arginine is
hydroxylated to form L-NHA and in the second
step L-NHA is converted to citrulline and •NO.H2N NH2
NH
COOH3N
H2N N
NH
COOH3N
OH H2N O
NH
COOH3N
NADPH
O2
•NO
L-Arginine L-NHA L-Citrulline
O2
1/2 NADPH
Structure
Figure 2
Proposed reaction mechanisms. The first step
may be catalyzed by the heme in a reaction
analogous to the hydroxylation by cytochrome
P450, using reducing equivalents derived
from NADPH via the reductase domain. The
subsequent conversion of L-NHA to products
is proposed to involve reaction of O2 with
ferrous heme and the abstraction of H• from 
L-NHA. The stoichiometries for NADPH [35]
are consistent with the donation of two
electrons from NADPH in the first step and
one electron in the second step.
PPIX
PPIX
1/2 NADPH
O2
PPIX
O2
NADPH
PPIX
+•N=O
PPIX
••
••
NH
H3N
FeIII
NH
H2N NH2
COO H3N
H2N N
COO
OH
NH
H3N
FeIIO2
H2N N
COO
OH
NH
H3N
FeIII
H2N N
COO
NH
H3N
FeIII
H2N
COO
O•
NH
H3N
FeIII
H2N O
COO
OOH
O O
N
O
PPIX FeIIIOO
Structure
the other NOS isoforms. The dimer interface in iNOS
was found to be extensive, involving many elements of the
structure; within the dimer interface the monomers were
covalently locked together by a disulfide bridge connecting
the conserved Cys109 residues from each chain.
The most recent structure analysis of NOS, by Poulos and
colleagues [11], again describes a dimer of the heme-con-
taining oxygenase domains, but examines eNOS expressed
as a full-length protein (except for the excision of ~23
residues of the CaM-binding sequence) and then clipped
by tryptic cleavage. The nominal resolution of the struc-
ture, 1.90 Å, is significantly higher than the 2.3–2.6 Å in
earlier analyses of iNOS, and the average individual atom
temperature factor, <B>, is smaller (~40 Å2). The model
of eNOS is based on a completely independent structure
analysis that combined multiple isomorphous replacement
(MIR) and multiwavelength anomalous dispersion (MAD)
phasing and utilized the statistical methods deployed in
SHARP [12]. Data were obtained for crystals complexed
with L-arginine (both in the presence and absence of H4B),
and with the inhibitor S-ethylthiourea plus L-arginine. No
quantitative structural matches have yet been made, but
the overall monomer fold of residues 66–498 (iNOS) and
67–482 (eNOS) appears to be very similar. The structural
similarity is consistent with the residue identity of ~50%
and with the presumption that the fundamental chemistry
is the same in all NOS isoforms. In the eNOS structure,
however, the dimer interface includes a metal center in
which Zn is ligated to four conserved cysteine residues, two
from each monomer (Figures 3 and 4). This coordination to
symmetry-related pairs of residues is unusual and places Zn
on the molecular dyad. The Zn(Cys)4 site, and its relation
to the H4B and heme cofactors of the oxygenase domains,
are central themes of the paper by Poulos and colleagues.
Figure 4 shows the spatial relationships among the heme
and H4B cofactors and the Zn(Cys)4 center. L-Arginine is
bound at the substrate site on the proximal side of the
heme. The higher resolution structure confirms all the
interactions of the functionally enigmatic H4B that were
found in the earlier analysis by Crane et al. [10]. In par-
ticular, stacking against a tryptophan residue (Trp449 in
eNOS), interaction of a heme propionate with the NH(3)
and exocyclic NH2 groups of H4B, and backbone inter-
actions with H4B ring nitrogens N(1) and N(8) are dupli-
cated in both structures. Contacts between residues from
the symmetry-related monomer and H4B seem to provide
a basis for the observed thermodynamic linkage between
H4B binding and dimerization [8], although the H4B-free
structure of eNOS remains dimeric (see below). The jux-
taposition of cofactors can readily account for observed
spectral interactions between the heme and H4B.
The Zn(Cys)4 site
Two conserved cysteine residues from each monomer
chain, Cys96 and Cys101, form a tetrahedral metal-binding
site in eNOS (Figure 4). The electron-density maps [11] are
consistent with high occupancy of the metal at this position.
Zn was identified as the predominant transition metal at the
(Cys)4 site in crystalline iNOS by X-ray absorbance scans
that were part of the MAD experiments intended for
phasing of the reflections, and by refinement of the anom-
alous scattering contributions. Discovery of this novel metal
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Figure 3
Stereoview of the monomer of the eNOS
oxygenase domain with bound cofactors,
viewed approximately perpendicular to the
dimer interface. The local twofold axis passes
through the Zn ion. The L-arginine substrate is
presumed to approach the heme from the right
along a path that lies approximately in the plane
of the paper. Features that contribute to the
dimer interface (orange) are labeled: residues
67–109, which includes the Zn-binding
residues; residues 362–411, which form
helices α7 and α8; and the long partly helical
loop formed by residues 444–469 that wraps
around the bound H4B molecules. Bound
heme, H4B and arginine are shown in red, blue
and green stick representation, respectively;
the Zn ion is shown as a red sphere.
(Cys)4 ‘cofactor’ in NOS poses questions about its role in
the structure and function of the enzyme.
An initial question might be whether Zn is in fact the native
metal in this site. The content and stoichiometry of transi-
tion metals (apart from heme iron) are variable in NOS
preparations, with levels of Zn that are near 0.5 per mono-
mer, as expected for the new site at the dimer interface. For
example, it has been reported that iNOS can be isolated
with a Zn content of 0.36 per heme; preparations of nNOS,
however, contained almost a full equivalent of Cu [13]. The
transition metal in both of these proteins as isolated could
be replaced by Fe in the presence of L-arginine, H4B and
dithiothreitol (DTT), with a significant increase in NOS
activity. It will thus be important to know how the activity
of NOS depends on an intact metal(Cys)4 center. A careful
correlation of NOS activity with metal content might estab-
lish the functionality of the metal(Cys)4 center.
The two reported structures of oxygenase dimers [10,11]
differ in the region spanning residues 90–110, where the
Zn(Cys)4 center is observed in eNOS but not in iNOS.
The cysteine residues that contribute to this site form part
of a conserved CysX4Cys sequence motif. These con-
served cysteine residues occur at positions 104 and 109 in
iNOS, but in the iNOS structure Cys104 is disordered and
the Cys109 residues were modeled to form a disulfide
bridge that links the monomers across the local dyad. The
metal site is probably not a unique feature that truly dis-
tinguishes eNOS from iNOS; incorporation of the metal in
one structure and not in the other may instead be the result
of differences in expression, purification and/or crystalliza-
tion conditions. Enzymatic activities are again an impor-
tant test of the functional ‘relevance’ of the structures.
Unfortunately, assays of the species that were crystallized
are not simple, as both are truncated fragments lacking the
reductase domains.
The position of Zn on the molecular twofold axis will be
of particular interest to structural biologists. Mononuclear
metal sites bridging symmetric dimers seem relatively rare.
One such site involving Zn occurs in the structure of human
interferon α2b, where the Zn is bound by four glutamate
residues — two from each monomer [14]. Similarly, a Zn
site is found in a dimer of the superantigen SPE-C [15].
Instances of Zn sites connecting asymmetric dimers are also
known [16]. A more distant analog is the Fe4S4 cluster that
is shared by monomers of the Fe protein of nitrogenase [17].
A survey of known Zn(Cys)4 sites in proteins assigns both
functional and structural roles to these centers; the proto-
typical structural Zn(Cys)4 sites occur in alcohol dehy-
drogenase [18] and aspartate transcarbamoylase [19]. A
series of functional Zn(Cys)4 or Zn(Cys)3 sites was recently
characterized and studied in proteins and model systems
[20–22]. In these cases, the Zn acts to activate one of
the ligand thiolates for methylation (alkylation). It seems
unlikely that such an activity could have any relevance in
the catalytic cycle of NOS. Furthermore, any functional
role for the metal(Cys)4 center in NOS would require its
involvement in the reactions at both active sites of the
dimer. Assuming that the native metal is indeed zinc, a
structural role for the bridging Zn(Cys)4 site in NOS
seems most plausible and would be consistent with the
properties of mutants in which one or other of the con-
served cysteine ligands has been modified [23–25].
The role of tetrahydrobiopterin (H4B)
The role of H4B is arguably the most intriguing aspect of
structure/function relationships in NOS. Is H4B involved in
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Figure 4
The arrangement of cofactors and substrate in
monomer A of eNOS, oriented to show the
surroundings of H4B (blue) and its relation to
the Zn(Cys)4 site. The backbone of monomer
A is in cyan and monomer B is in yellow.
Individual residues that interact with
H4B — Ser104, Trp449 and Arg367 (from
monomer A) and Trp447, Phe462 and
His463 (from monomer B) — are in orange
and purple, respectively. Distances from Zn to
the heme Fe and from Zn to the H4B C4a
atom are ~23 Å and 16 Å, respectively.
the chemistry that converts L-arginine to citrulline and •NO,
or is its role strictly structural? The requirement for fully
reduced H4B in order to form L-NHA, and the stimulation
of •NO formation from L-arginine by reconstitution with Fe
[13], have prompted speculation that the initial hydroxyla-
tion of L-arginine mimics the hydroxylation of aromatic
amino acids [26], and occurs at the pterin moiety rather than
at the heme [27]. These reactions produce pterin hydroxy-
lated at position 4a, which is then converted to the quini-
noid tautomer of H2B by dehydration. However, structural
superpositions show that an Fe site comparable to that in
the Fe- and pterin-dependent tyrosine hydroxylase [28]
would have to lie ‘above’ the pterin moiety in Figure 4.
Neither room nor ligands can be found for such an accessory
Fe2+ in the structures of the NOS dimers. Thus the current
structures are not compatible with participation of H4B as a
cosubstrate in the hydroxylation of L-arginine.
The interactions of H4B with NOS provide further argu-
ments against a role for the pterin as an oxidizable cosub-
strate. Enzymes that utilize folates or pterins as cofactors
or substrates can be grouped into functional categories.
Using the known structures of pterin- and folate-depen-
dent enzymes, one can correlate the interactions of pterin
cofactors with the chemistry that is promoted by their
protein hosts. Raman et al. [11] employed this structural
logic to evaluate the possible functions of H4B in NOS.
They noted in particular that interactions of N(3) and the
exo 2-NH2 of H4B with a carboxylate group, which is pro-
vided in novel fashion in NOS by a heme propionate, are
not found in the Fe/pterin hydroxylases [28] or in other
enzymes [29,30] where quininoid H2B, with a pyridine-
like N(3), is an intermediate.
Rather than consigning the H4B to a passive structural role,
Raman et al. propose that it participates in electron transfer,
undergoing transient one-electron oxidation to the semi-
quinone cation [11]. They postulate the cationic species
because L-arginine binds in the H4B-binding site when the
protein is crystallized with S-ethylisothiourea and L-argi-
nine in the absence of H4B. One-electron chemistry of
tetrahydropterins has precedents in model systems, espe-
cially under acidic conditions [26]. The formation of pterin
radicals has been invoked in the activation of phenylalanine
hydroxylase [29], but has not been conclusively demon-
strated as part of the catalytic pathway in NOS or any other
pterin-dependent enzyme. The potential participation of a
pterin semiquinone in NOS chemistry is based on the well
known one-electron chemistry carried out by flavins.
However, pterin radicals are much less stable than the cor-
responding flavin radicals [26,30].
The specific proposal put forth by Raman et al. includes
H4B in the electron-transfer chain from NADPH to the
heme and led us to develop the reaction cycles shown in
Figure 5. From the similarity of the NOS reductase
domain to P450 reductase, it is assumed that the overall
electron transfer would proceed in the linear sequence:
NADPH→FAD→FMN→H4B→heme. The essential
role of H4B in the oxidation of L-arginine (Figure 5a)
would be the donation of the second electron that con-
verts the heme–Fe(III)–O2• complex to the Fe(III) perox-
ide and is required for L-NHA formation. In the next
cycle of the NOS reaction, L-NHA is converted to L-cit-
rulline and •NO. This conversion is proposed to proceed as
shown in Figure 5b. In this cycle the second required elec-
tron is derived from L-NHA as H•, yielding L-NHA• and
the heme–Fe(III) hydroperoxide. Other evidence supports
the direct attack of the ferric peroxide species on L-NHA•
to yield the final products as shown in Figure 2 [6,7].
The idea of using the pterin-reducing equivalents in this
way is intriguing. Bec et al. [31] recently inferred the
involvement of a pterin radical from an intermediate spec-
trum observed during the decay of a heme–Fe(II)–oxy
complex of NOS in the presence of L-arginine and H4B.
They suggested that this intermediate might be the
(FeO)3+ species formed after donation of an electron by
H4B (Figure 5). Raman et al. base their hypothesis, which
would set a new precedent for pterin enzymes, partly on
these observations. They suggest that the environment of
H4B in NOS might help to overcome the otherwise very
unfavorable energetics for semiquinone formation: the
known redox potentials do not favor electron transfer
from H4B to either Fe(III) or to Fe(III)–O2•. In view of
what is known about the stabilities of pterin radicals, it
will be a challenge to demonstrate that they are kineti-
cally competent intermediates. Thus it will be critical,
but not easy, to document what might be a truly novel
feature of catalysis by NOS.
The proposal that H4B is required as a component of the
electron-transfer chain, forming •H3B as an intermediate,
leaves several key questions unanswered. It fails to explain
why L-arginine is not a substrate in the peroxide shunt and
cannot be oxidized by iodosobenzene as a source of oxene
oxygen [7]. Questions about the oxidation of L-NHA also
remain. What is the chemistry that determines the switch
to L-NHA as the source of the second electron? The
ability of L-arginine, but not L-NHA, to protonate Fe(III)–
O–O– may be critical, as may differences in redox poten-
tial between L-arginine and L-NHA. The observation that
NADPH will support catalysis of the H4B-free enzyme
clearly points to some role of H4B in the oxidation of
L-NHA, which yields different products in the H4B-free
and H4B-bound forms of NOS [4].
Electron transfer from the reductase domain
Both Crane et al. and Raman et al. speculate about how the
FMN moiety of the reductase domain may bind to the
oxygenase domain. Crane and coworkers [10] propose the
surface in the vicinity of Trp366, opposite the presumed
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substrate channel (and on the left-hand side of the
monomer depicted in Figure 3) as a likely binding site. In
contrast, Raman and coworkers [11] favor binding in the
vicinity of Zn(Cys)4, a region that is both accessible and
positively charged. The electrostatic potential is important
because the flavodoxin-like donor is expected to be nega-
tively charged, although alignment of the Escherichia coli or
Anabaena flavodoxin sequences with NOS [32] suggest
that some of the acidic groups surrounding FMN have
been replaced in NOS. Binding near the Zn(Cys)4 center
would position the electron donor nearer to the pterin
moiety (facilitating electron transfer via H4B) and farther
from the heme than the site proposed by Crane et al. This
orientation of electron donor and heme resembles the
arrangement observed in a complex between the P450 and
FMN domains of cytochrome P450BM-3 [33].
Organization and formation of the active dimer
The dimer interface of NOS is extensive, involving
symmetric contacts of polypeptide segments comprising
residues 67–107, 362–411 and 449–469 (Figure 3). It is
notable that residues from segments 67–107 and 447–469
contribute to both the interface and the H4B binding sites.
Earlier data had clearly shown [25,34] the peptide segment
67–110 to be critical for dimerization. This region of the
chain forms an initial hairpin and ends with the loop that
binds Zn in eNOS, making numerous intermonomer inter-
actions. The loss of H4B and activity that accompany disso-
ciation to the monomer are easily rationalized from the
precarious position of H4B at the interface. Comparisons of
the structures of the monomeric and dimeric forms of
iNOS [10] show dramatic differences at the face of the
monomer that is involved in dimer formation (Figure 3).
The helical loop or ‘lariat’ [10], formed by residues
440–465 in eNOS, is not ordered in the H4B-free monomer
but contacts both H4B molecules in the dimer structures.
Dimerization and incorporation of H4B are also accompa-
nied by shifts in the positions of helix α7a (residues
370–378 in iNOS) and helix α9 [10].
Raman et al. view the formation of the dimer with its full
complement of cofactors somewhat differently from the
earlier studies describing the iNOS structure. From their
comparisons with the monomer, Crane et al. [10] regarded
H4B binding as critical in bringing together the structural
elements of the intact active dimer, although other data
show that dimeric species can form in the absence of H4B
[4]. However, Poulos and coworkers crystallized eNOS in
the absence of H4B and obtained a three-dimensional struc-
ture isomorphous with the H4B-bound form; H4B could be
added to the crystals without perturbing the structure. In
this case, other interactions are sufficient to maintain the
dimer structure in the absence of H4B. It has thus become
clear from this latest structure and biochemical studies [4]
that H4B binding is not a prerequisite for dimer formation.
This does not contradict the many observations that H4B
indeed stabilizes the active dimer of NOS.
An important feature of the ‘new’ Zn(Cys)4 site is its
potential role in the formation and stabilization of dimeric
NOS. A bridging metal ion may be a key structural feature
in NOS, which utilizes parts of two monomers in such an
intricate way to form its active site(s). It will be instructive
to re-examine experiments on dimer–monomer equilibria
with the realization that Zn or another transition metal
may be a player in the intermonomer interactions. This
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Figure 5
Reaction cycles for the oxidation of L-arginine
and L-HNA, assuming electron transfer to
heme via H4B. (a) In cycle 1 two electrons are
derived from NADPH via the transfer chain
that includes H4B. Heterolytic cleavage of the
O–O bond of Fe(III)OOH then yields the
(FeO)3+ intermediate, which is competent to
carry out the hydroxylation of L-arginine. (b) In
cycle 2 the first electron comes from NADPH
and the second from the substrate. A peroxide
shunt can function in cycle 2, converting
Fe(III) directly to Fe(III)OOH, which reacts
with L-NHA to yield the predicted products 
L-citrulline and NO– [6,7]. These schemes do
not preclude the possibility that the role of
H4B in the first electron-transfer step, where
Fe(III) is reduced to Fe(II), is to act as part of a
tunneling pathway for long-distance electron
transfer.
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new-found structural feature will surely prompt further in-
depth studies on the effects of mutation of the conserved
cysteine residues.
Note added in proof
Since this article was submitted, a paper describing the structures of
the heme domains of human iNOS and eNOS, each with a Zn(Cys)4
site, has been published (Fischmann, T.O., et al., & Weber, P.C. (1999).
Structural characterization of nitric oxide synthase isoforms reveals strik-
ing active-site conservation. Nat. Struct. Biol. 6, 233-242).
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